Cun Wang

8.2k total citations · 4 hit papers
92 papers, 5.0k citations indexed

About

Cun Wang is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Cun Wang has authored 92 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 23 papers in Cancer Research and 13 papers in Biomedical Engineering. Recurrent topics in Cun Wang's work include Advanced biosensing and bioanalysis techniques (26 papers), Electrochemical sensors and biosensors (9 papers) and RNA modifications and cancer (9 papers). Cun Wang is often cited by papers focused on Advanced biosensing and bioanalysis techniques (26 papers), Electrochemical sensors and biosensors (9 papers) and RNA modifications and cancer (9 papers). Cun Wang collaborates with scholars based in China, Netherlands and United States. Cun Wang's co-authors include Wenxin Qin, Chen Yang, Haojie Jin, René Bernards, Yingzi Fu, Ming Yao, Andrew X. Zhu, Linmeng Zhang, Guang‐Zhi Jin and Hailin Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Gastroenterology.

In The Last Decade

Cun Wang

91 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolving therapeutic landscape of advanced hepatocellular carcinoma

2022 450 citations Chen Yang, Hailin Zhang et al. profile →
STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4

2017 436 citations Hui Wang, Xisong Huo et al. Molecular Cancer profile →
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity

2021 416 citations Botai Li, Cun Wang et al. profile →
Precision treatment in advanced hepatocellular carcinoma

2024 188 citations Chen Yang, Haigang Geng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cun Wang China	37	3.6k	2.0k	683	579	520	92	5.0k
Kangsheng Tu China	43	3.5k 1.0×	2.4k 1.2×	719 1.1×	422 0.7×	487 0.9×	110	5.4k
Ting Deng China	43	4.8k 1.3×	3.3k 1.7×	844 1.2×	926 1.6×	871 1.7×	203	6.7k
Maria Letizia Taddei Italy	37	2.6k 0.7×	1.5k 0.8×	1.0k 1.5×	411 0.7×	270 0.5×	89	4.4k
Wenxin Qin China	44	5.3k 1.5×	3.3k 1.7×	1.4k 2.0×	853 1.5×	336 0.6×	137	7.7k
Gonghui Li China	33	1.9k 0.5×	1.1k 0.6×	373 0.5×	694 1.2×	640 1.2×	167	3.6k
Ji Cao China	43	3.2k 0.9×	1.2k 0.6×	1.2k 1.7×	897 1.5×	255 0.5×	142	5.4k
Niramol Savaraj United States	47	3.2k 0.9×	1.7k 0.9×	2.4k 3.4×	741 1.3×	335 0.6×	211	6.9k
Gabi U. Dachs New Zealand	33	2.4k 0.7×	1.9k 1.0×	769 1.1×	315 0.5×	349 0.7×	85	4.5k
Young Hee Ko United States	31	3.7k 1.0×	2.0k 1.0×	663 1.0×	360 0.6×	175 0.3×	69	5.1k
Haojie Jin China	30	2.7k 0.7×	1.8k 0.9×	541 0.8×	411 0.7×	228 0.4×	65	3.7k

Countries citing papers authored by Cun Wang

Since Specialization

Citations

This map shows the geographic impact of Cun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cun Wang more than expected).

Fields of papers citing papers by Cun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cun Wang. The network helps show where Cun Wang may publish in the future.

Co-authorship network of co-authors of Cun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Cun Wang. A scholar is included among the top collaborators of Cun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cun Wang. Cun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Cun, et al.. (2025). Digital CSR impact on Chinese auto brands: Mediating and moderating customer satisfaction and engagement. Acta Psychologica. 258. 105155–105155.

Wang, Cun, Zhengwei Xiong, Yaoyao Zhang, et al.. (2024). Novel pore confinement enhanced europium functionalized porphyrin covalent organic framework electrochemiluminescence microreactor and its application to microRNA-21 detection. Sensors and Actuators B Chemical. 418. 136314–136314. 10 indexed citations

Wang, Jun, Long Liao, Beiping Miao, et al.. (2024). Deciphering the role of the MALT1–RC3H1 axis in regulating GPX4 protein stability. Proceedings of the National Academy of Sciences. 122(1). e2419625121–e2419625121. 5 indexed citations

Wang, Cun, et al.. (2023). Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer. Oncogene. 42(20). 1620–1633. 39 indexed citations

Geng, Haigang, Xiangyu Tang, Xiaojun Zhang, et al.. (2023). Leveraging synthetic lethality to uncover potential therapeutic target in gastric cancer. Cancer Gene Therapy. 31(2). 334–348. 2 indexed citations

Mulero‐Sánchez, Antonio, Christel Ramirez, Aimée du Chatinier, et al.. (2023). Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinoma. Molecular Oncology. 17(6). 964–980. 11 indexed citations

Liu, Zhicheng, Dongxu Lin, Yi Zhou, et al.. (2022). Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma. Scientific Reports. 12(1). 13222–13222. 2 indexed citations

Wang, Cun, et al.. (2022). Novel electrochemiluminescence luminophore based on flower-like binuclear coordination polymer for high-sensitivity detection of tetracycline in food products. Food Chemistry. 403. 134376–134376. 29 indexed citations

Li, Yan, Chen Yang, Zhicheng Liu, et al.. (2022). Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy. Molecular Cancer. 21(1). 2–2. 26 indexed citations

10.

Jochems, Fleur, Bram Thijssen, Giulia De Conti, et al.. (2021). The Cancer SENESCopedia: A delineation of cancer cell senescence. Cell Reports. 36(4). 109441–109441. 122 indexed citations

11.

Liu, Pingkun, Hui Meng, Qian Han, et al.. (2021). Determination of ascorbic acid using electrochemiluminescence sensor based on nitrogen and sulfur doping graphene quantum dots with luminol as internal standard. Microchimica Acta. 188(4). 120–120. 10 indexed citations

12.

Chen, Yang, Yuchen Guo, Yi‐Wen Huang, et al.. (2021). Mapping the landscape of synthetic lethal interactions in liver cancer. Theranostics. 11(18). 9038–9053. 21 indexed citations

13.

He, Jia, Qiaozhu Zuo, Bo Hu, et al.. (2019). A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA. Cancer Letters. 450. 98–109. 98 indexed citations

14.

Wu, Hai-Qiu, Cun Wang, Jiaxin Sun, et al.. (2019). Self-Assembled and Self-Monitored Sorafenib/Indocyanine Green Nanodrug with Synergistic Antitumor Activity Mediated by Hyperthermia and Reactive Oxygen Species-Induced Apoptosis. ACS Applied Materials & Interfaces. 11(47). 43996–44006. 39 indexed citations

15.

Wang, Cun, Haojie Jin, Dongmei Gao, et al.. (2018). Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer. Journal of Hepatology. 69(5). 1057–1065. 73 indexed citations

16.

Wang, Hui, Xisong Huo, Xin‐Rong Yang, et al.. (2017). STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Molecular Cancer. 16(1). 136–136. 436 indexed citations breakdown →

17.

Zhang, Yurong, Xuemei Tao, Guang‐Zhi Jin, et al.. (2016). A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma. Theranostics. 6(4). 558–570. 42 indexed citations

18.

Zhou, Rong, Cun Wang, Bin Lin, et al.. (2015). Chronic treatment of caffeine and adenosine A2A receptor antagonist KW6002 selectively protects against oxygen-induced retinal neovascular damage in mice. Investigative Ophthalmology & Visual Science. 56(7). 214–214. 1 indexed citations

19.

Luo, Qin, Cun Wang, Guang‐Zhi Jin, et al.. (2015). LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway. Carcinogenesis. 36(10). 1201–1212. 58 indexed citations

20.

Wang, Cun. (2011). Analysis on current situation of doing their duty among maternal&child health care centers in 2008. Zhongguo fuyou baojian. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact